Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Augmedix Inc (AUGX)

Augmedix Inc (AUGX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 62,867
  • Shares Outstanding, K 37,421
  • Annual Sales, $ 22,170 K
  • Annual Income, $ -17,850 K
  • 60-Month Beta -0.81
  • Price/Sales 2.15
  • Price/Cash Flow N/A
  • Price/Book 9.17
Trade AUGX with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.15
  • Number of Estimates 1
  • High Estimate -0.15
  • Low Estimate -0.15
  • Prior Year -0.16
  • Growth Rate Est. (year over year) +6.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3200 +25.00%
on 01/04/23
1.7800 -7.30%
on 01/24/23
+0.0950 (+6.11%)
since 01/03/23
3-Month
1.0100 +63.37%
on 12/13/22
1.9200 -14.06%
on 11/15/22
+0.1325 (+8.73%)
since 11/03/22
52-Week
1.0100 +63.37%
on 12/13/22
3.3700 -51.04%
on 03/25/22
-0.7500 (-31.25%)
since 02/03/22

Most Recent Stories

More News
Phio Pharmaceuticals Corp. (PHIO) Reports Q3 Loss, Lags Revenue Estimates

Phio Pharmaceuticals Corp. (PHIO) delivered earnings and revenue surprises of -172.22% and 100%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

PHIO : 6.29 (+2.28%)
AUGX : 1.7100 (+1.79%)
Health Catalyst (HCAT) Reports Q3 Loss, Tops Revenue Estimates

Health Catalyst (HCAT) delivered earnings and revenue surprises of 35% and 2.25%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

HCAT : 14.72 (-0.27%)
AUGX : 1.7100 (+1.79%)
Clover Health Investments, Corp. (CLOV) Reports Q3 Loss, Tops Revenue Estimates

Clover Health Investments, Corp. (CLOV) delivered earnings and revenue surprises of 48.39% and 3.34%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for...

CLOV : 1.3200 (+0.76%)
AUGX : 1.7100 (+1.79%)
Augmedix - Trio Health - CIIC First of its Kind Real-World Patient Ecosystem - Standardizing Relevant Clinical Data at the Point of Care

SAN FRANCISCO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Today, Trio Health (Trio) and Augmedix (Nasdaq: AUGX), in partnership with the Consortium of...

AUGX : 1.7100 (+1.79%)
Augmedix to Report Second Quarter 2022 Financial Results on August 8, 2022

SAN FRANCISCO, July 25, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services,...

AUGX : 1.7100 (+1.79%)
Augmedix to Present at the William Blair 42nd Annual Growth Stock Conference

SAN FRANCISCO, May 26, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services,...

AUGX : 1.7100 (+1.79%)
Augmedix Reports First Quarter 2022 Financial Results

SAN FRANCISCO, May 09, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services,...

AUGX : 1.7100 (+1.79%)
Augmedix to Report First Quarter 2022 Financial Results on May 9, 2022

SAN FRANCISCO, April 25, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services,...

AUGX : 1.7100 (+1.79%)
Augmedix to Participate at the 2022 Lytham Partners Spring Investor Conference

SAN FRANCISCO, March 29, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services,...

AUGX : 1.7100 (+1.79%)
Augmedix Reports Fourth Quarter and Full Year 2021 Financial Results

SAN FRANCISCO, March 21, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services,...

AUGX : 1.7100 (+1.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Augmedix Inc. is a provider of remote medical documentation and live clinical support. Augmedix Inc. is based in SAN FRANCISCO, Calif.

See More

Key Turning Points

3rd Resistance Point 1.9467
2nd Resistance Point 1.8533
1st Resistance Point 1.7667
Last Price 1.7100
1st Support Level 1.5867
2nd Support Level 1.4933
3rd Support Level 1.4067

See More

52-Week High 3.3700
Fibonacci 61.8% 2.4685
Fibonacci 50% 2.1900
Fibonacci 38.2% 1.9115
Last Price 1.7100
52-Week Low 1.0100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar